 BioReference Laboratories, Inc., an OPKO Health company NASDAQ: OPK, today announced a collaboration with the State of New Jersey to provide coronavirus disease 2019 COVID-19 testing across the State. BioReference will provide testing for the first NJ drive-through facilities in Burlington, Essex 